Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a pseudogene homologous to the myxovirus resistance protein 1 (MX1/MxA), which belongs to the dynamin-like GTPase family and is well known for its antiviral roles in mammals[1][2][4]. However, pseudogenes like ENSG00000250505 do not code for functional proteins, and there is no evidence that this genomic locus serves any biological function, acts as a therapeutic target, or interacts with drugs. The confusion arises from its similarity to functional genes that encode active antiviral proteins (such as MX1/MxA), which are critical for innate immune response against a range of viruses including influenza and other RNA viruses[1][2][4]. Unless later found to have regulatory RNA or other rare functions, the designation as a "novel myxovirus resistance protein pseudogene" means it should not be used as a canonical target in drug discovery or clinical diagnostics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel myxovirus resistance protein pseudogene (ENSG00000250505).